ArticleChemSusChem2026
Oxidative Bagasse Fractionation for Its Efficient Utilization Based on a Lignin-First Approach.
Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In order to tackle the challenges of biological refining, including strong acids/alkalis and high temperatures, the aerobic oxidation was implemented in the pretreatment of biomass for one-pot extraction and separation of lignin and carbohydrates by combining the processes of biomass hydrolytic fractionation and in situ lignin oxidative modification. As expected, the yields of oxidized lignin and carbohydrate residue under optimized pretreatment condition are up to 17.1% and 59.9%, respectively, and the oxidized lignin exhibits improved depolymerization performance, giving the phenolic monomer yield of around 245.0 mg g
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.